TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive Grantees Not In Danger Of Losing Cost-Free Biological Materials, But Can’t Have Chemicals September 9, 1977
TCL Archive CCIRC Fears Multimodality Studies Threatened By Cooperative Groups’ Misapplication Of Funds January 14, 1977
